The Goldman Sachs Group Begins Coverage on HealthEquity (NASDAQ:HQY)

The Goldman Sachs Group began coverage on shares of HealthEquity (NASDAQ:HQY) in a research report report published on Friday, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $108.00 price target on the stock.

A number of other research firms also recently issued reports on HQY. Royal Bank of Canada reissued an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Bank of America raised their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Barrington Research reaffirmed an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research note on Friday, September 20th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Finally, BTIG Research increased their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $107.23.

HealthEquity Trading Up 3.4 %

NASDAQ HQY opened at $98.98 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. HealthEquity has a fifty-two week low of $62.10 and a fifty-two week high of $101.17. The stock has a market cap of $8.64 billion, a P/E ratio of 82.48, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52. The stock has a 50 day simple moving average of $85.02 and a two-hundred day simple moving average of $81.09.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. The company had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. On average, analysts forecast that HealthEquity will post 2.27 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,536 shares of company stock valued at $884,517. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Several large investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in HealthEquity by 1.7% in the first quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock worth $715,783,000 after purchasing an additional 149,133 shares during the last quarter. Wasatch Advisors LP lifted its stake in shares of HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after purchasing an additional 483,269 shares during the period. State Street Corp lifted its stake in shares of HealthEquity by 0.8% in the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after purchasing an additional 23,613 shares during the period. Clearbridge Investments LLC boosted its holdings in shares of HealthEquity by 1.9% in the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after buying an additional 43,491 shares during the last quarter. Finally, Mackenzie Financial Corp grew its position in HealthEquity by 16.0% during the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after buying an additional 325,906 shares during the period. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.